Percutaneous extraction of cardiac pacemaker and implantable cardioverter defibrillator leads with evolution mechanical dilator sheath: a single-centre experience

被引:36
|
作者
Oto, Ali [1 ]
Aytemir, Kudret [1 ]
Yorgun, Hikmet [1 ]
Canpolat, Ugur [1 ]
Kaya, Ergun Baris [1 ]
Kabakci, Giray [1 ]
Tokgozoglu, Lale [1 ]
Ozkutlu, Hilmi [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey
来源
EUROPACE | 2011年 / 13卷 / 04期
关键词
Evolution mechanical sheath; Percutaneous lead extraction; TRANSVENOUS PACEMAKER; INITIAL-EXPERIENCE; INFECTIONS; MANAGEMENT; TRIAL;
D O I
10.1093/europace/euq400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The growing problem with endocardial lead infections and lead malfunctions has increased the interest in percutaneous lead removal technology. In this report, we present our initial experience in percutaneous lead extraction with a novel hand-powered sheath, the Evolution mechanical dilator sheath. Methods and results During 13 months between June 2009 and July 2010, 41 leads in 23 patients were removed. All of the extracted leads were >12 months old, and indications for extraction were based on the recommendations of the Heart Rhythm Society. The leads were removed by using the Evolution mechanical dilator sheath (Cook Medical) with the rotational cutting force only, without laser or radiofrequency energy. Indications for lead removal included cardiac device infection in 7 (30.4%) cases, lead malfunction in the 15 (65.2%) cases, and lead displacement in the remaining 1 case (4.4%). In 14 (60.9%) cases, the extracted device was a pacemaker, and implantable cardioverter defibrillators (ICD) in 9 (39.1%) of them. Among 41 leads, 25 (60.9%) were right ventricular, 14 (34%) were atrial, and 2 (4.8%) were coronary sinus electrode. The median time from the preceding procedure was 74 months (25-180 months). Complete procedural success with Evolution system alone was achieved in 19 (82%) patients (35 leads). Four leads were completely removed with snaring and in two leads, partial success was achieved with a remaining ventricular tip smaller than 1.5 cm. Clinical success was 100%, and all of the patients discharged uneventfully without a major complication. Conclusions Our experience confirms that the mechanical technique with Evolution system is an effective first-line method for chronically implanted pacemaker/ICD leads. Continued investigation is required to evaluate success and complication rates in comparison with other techniques.
引用
收藏
页码:543 / 547
页数:5
相关论文
共 50 条
  • [41] Safety and efficacy of subcutaneous implantable cardioverter defibrillator (S-ICD): a single centre experience
    Doyle, C.
    Byrne, L.
    Low, R.
    Galvin, J.
    HEART, 2023, 109 (SUPPL_6) : A11 - A11
  • [42] Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience
    Migliore, Federico
    Silvano, Maria
    Zorzi, Alessandro
    Bertaglia, Emanuele
    Siciliano, Mariachiara
    Leoni, Loira
    De Franceschi, Pietro
    Iliceto, Sabino
    Corrado, Domenico
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (07) : 485 - 493
  • [43] Effectiveness of implantable cardiac defibrillators for primary prevention: A single-centre experience
    Maranda, R.
    Nguyen, V.
    Essebag, V.
    Giannetti, N.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 68C - 68C
  • [44] PERMANENT PACEMAKER AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR INFECTIONS: SEVEN YEARS OF DIAGNOSTIC AND THERAPEUTIC EXPERIENCE OF SINGLE CENTER
    Okutucu, Sercan
    Cengiz, Mustafa
    Sahin, Abdurrahman
    Karakulak, Ugur Nadir
    Ascioglu, Sibel
    Kaya, Ergun Baris
    Aytemir, Kudret
    Kabakci, Giray
    Tokgozoglu, Lale
    Nazli, Nasih
    Ozkutlu, Hilmi
    Oto, Ali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 : S21 - S21
  • [45] Permanent Pacemaker and Implantable Cardioverter Defibrillator Infections: Seven Years of Diagnostic and Therapeutic Experience of a Single Center
    Cengiz, Mustafa
    Okutucu, Sercan
    Ascioglu, Sibel
    Sahin, Abdurrahman
    Aksoy, Hakan
    Deveci, Onur Sinan
    Kaya, Ergun Baris
    Aytemir, Kudret
    Kabakci, Giray
    Tokgozoglu, Late
    Ozkutlu, Hilmi
    Oto, Ali
    CLINICAL CARDIOLOGY, 2010, 33 (07) : 406 - 411
  • [46] Initial experience of pacemaker and implantable cardioverter defibrillator lead extraction with the new GlideLight 80 Hz laser sheaths
    Hakmi, Samer
    Pecha, Simon
    Sill, Bjoern
    Reiter, Beate
    Willems, Stephan
    Aydin, Muhammet Ali
    Yildirim, Yalin
    Reichenspurner, Hermann
    Treede, Hendrik
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2014, 18 (01) : 56 - 60
  • [47] Percutaneous Pacemaker and Implantable Cardioverter-Defibrillator Lead Extraction in 100 Patients With Intracardiac Vegetations Defined by Transesophageal Echocardiogram
    Grammes, Jon A.
    Schulze, Christopher M.
    Al-Bataineh, Mohammad
    Yesenosky, George A.
    Saari, Christine S.
    Vrabel, Michelle J.
    Horrow, Jay
    Chowdhury, Mashiul
    Fontaine, John M.
    Kutalek, Steven P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (09) : 886 - 894
  • [48] Impact of diabetes as a risk factor in patients undergoing subcutaneous implantable cardioverter defibrillator implantation: A single-centre study
    Kaya, Elif
    Siebermair, Johannes
    Vonderlin, Nadine
    Hadjamu, Nino
    Azizy, Obayda
    Rassaf, Tienush
    Wakili, Reza
    DIABETES & VASCULAR DISEASE RESEARCH, 2020, 17 (02):
  • [49] Percutaneous extraction of endocardial leads - a single centre experience in 120 patients
    Kutarski, Andrzej
    Malecka, Barbara
    Rucinski, Piotr
    Zabek, Andrzej
    KARDIOLOGIA POLSKA, 2009, 67 (02) : 149 - 158
  • [50] Safety and effectiveness of transvenous extraction of pacemaker and implantable cardioverter-defibrillator leads in patients under or over 80 years of age
    Kempa, Maciej
    Budrejko, Szymon
    Piepiorka, Marta
    Rogowski, Jan
    Raczak, Grzegorz
    Kozlowski, Dariusz
    KARDIOLOGIA POLSKA, 2013, 71 (02) : 130 - 135